ACE and coronary artery disorder: There were no significant differences with respect to overall cardiovascular comorbidity between the three groups of patients (p = 0.337), however, coronary artery disease (p = 0.009) and a history of myocardial infarction (p = 0.001) was more prevalent in patients taking an ACE-inhibitor.